These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8758043)

  • 1. Anti-thrombotic therapy for non-rheumatic atrial fibrillation.
    More RS; Chauhan A
    QJM; 1996 Jun; 89(6):409-14. PubMed ID: 8758043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
    Lip GY; Lowe GD
    Br J Clin Pharmacol; 1996 May; 41(5):369-79. PubMed ID: 8735677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risks and benefits of antithrombotic therapy in chronic atrial fibrillation.
    Hankey GJ; Gray NJ
    Med J Aust; 1996 May; 164(10):624-6. PubMed ID: 8637471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antithrombotic treatment for atrial fibrillation.
    Nademanee K; Kosar EM
    Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of stroke].
    Preobrazhenskiĭ DV; Sidorenko BA; Kiktëv VG; Batyraliev TA; Pershukov IV
    Kardiologiia; 2005; 45(1):84-93. PubMed ID: 15699946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
    Lip GY; Lowe GD
    BMJ; 1996 Jan; 312(7022):45-9. PubMed ID: 8555864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Diner BM
    Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695
    [No Abstract]   [Full Text] [Related]  

  • 9. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
    Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.
    Kahn JK
    Postgrad Med; 1992 Sep; 92(3):119-24, 129-30. PubMed ID: 1518749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of nonvalvular atrial fibrillation: a comprehensive approach.
    Iuliano L; Di Matteo A; Straface G
    Indian J Med Sci; 2009 Sep; 63(9):419-30. PubMed ID: 19805924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].
    Bounhoure JP
    Bull Acad Natl Med; 2011; 195(4-5):963-74; discussion 974-7. PubMed ID: 22375363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
    Lip GY
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.